Apolipoprotein C-II promoter T → A substitution at position -190 affects on the transcription of the gene and its relationship to hyperlipemia

Biochemical and Biophysical Research Communications

Volumn 354, Issue 1, 2007, Pages 62-65

  Chen, Chun Hua ^a   Cao, Ying Lin ^a   Hu, Wei Cheng ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Apolipoprotein C II; Hyperlipemia; Luciferase expression; Promoter; Site directed mutation

Indexed keywords

ADENINE; APOLIPOPROTEIN C2; THYMINE;

APOC II GENE; ARTICLE; CHINESE; CONTROLLED STUDY; DNA SEQUENCE; GENE; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HETEROZYGOTE DETECTION; HOMOZYGOTE; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; IN VITRO STUDY; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; REGULATORY MECHANISM; SEQUENCE ANALYSIS; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION REGULATION; TRANSCRIPTOMICS;

AMINO ACID SUBSTITUTION; APOLIPOPROTEIN C-II; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTRIGLYCERIDEMIA; INFANT, NEWBORN; LIVER NEOPLASMS; MALE; MUTAGENESIS, SITE-DIRECTED; MUTATION; PROMOTER REGIONS, GENETIC; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 33846269258     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.12.154     Document Type: Article

References (15)

1. Havel R.J., Shore V.G., Shore B., and Bier D.M. Role of specific glycopeptides of human serum lipoproteins in the activation of lipoprotein lipase. Circ. Res. 27 (1970) 595-600
2. LaRosa J.C., Levy R.I., Herbert P., Lux S.E., and Fredrickson D.S. A specific apoprotein activator for lipoprotein lipase. Biochem. Biophys. Res. Commun. 41 (1970) 57-62
3. Hospattankar A.V., Fairwell T., Ronan R., and Brewer Jr. H.B. Amino acid sequence of human plasma apolipoprotein C-II from normal and hyperlipoproteinemic subjects. J. Biol. Chem. 259 (1984) 318-322
4. Breckenridge W.C., Little J.A., Steiner G., Chow A., and Poapst M. Hypertriglyceridemia associated with deficiency of apolipoprotein C-I. N. Engl. J. Med. 298 (1978) 1265-1273
5. Allan C.M., Walker D., Segrest J.P., and Taylor J.M. Identification and characterization of a new human gene (APOC4) in the apolipoprotein E, C-I, and C-II gene locus. Genomics 28 (1995) 291-300
6. Lusis A.J., Heinzmann C., Sparkes R.S., Scott J., Knott T.J., Geller R., Sparkes M.C., and Mohandas T. Regional mapping of human chromosome 19: organization of genes for plasma lipid transport (APOC1, -C2, and -E and LDLR) and the genes C3, PEPD, and GPI. Proc. Natl. Acad. Sci. USA 83 (1986) 3929-3933
7. Wei C.F., Tsao Y.K., Robberson D.L., Gotto Jr. A.M., Brown K., and Chan L. The structure of the human apolipoprotein C-II gene. Electron microscopic analysis of RNA: DNA hybrids, complete nucleotide sequence, and identification of 5′ homologous sequences among apolipoprotein genes. J. Biol. Chem. 260 (1985) 15211-15221
8. Vorgia P., Zannis V.I., and Kardassis D.A. Short proximal promoter and the distal hepatic control region-1 (HCR-1) contribute to the liver specificity of the human apolipoprotein C-II Gene. J. Biol. Chem. 273 (1998) 4188-4199
9. Kardassis D., Sacharidou E., and Zannis V.I. Transactivation of the human apolipoprotein C-II promoter by orphan and ligand-dependent nuclear receptors. The regulatory element C-IIC is a thyroid hormone response element. J. Biol. Chem. 273 (1998) 17810-17816
10. Tian C., Hu W., Chen R., and Shen B. The genetic analysis of apolipoprotein C-II in the parents of a malignant hyperlipidemia. Chin. J. Med. Genet. 20 (2003) 272
11. Feng X., Hu W., Zhang S., Liu F., Li L., Liu Y., Zhu Y., and Xu J. The initial research of malignant hyperlipemia in infancy. Chin. J. Med. Genet. 12 (1995) 366-367
12. Chen C., Cao Y., and Hu W. A single base mutation (T to A) at position-190 in the apolipoprotein C-II promoter with apolipoprotein C-II deficiency. Atherosclerosis 11 (2003) 509-511
13. Haberg B., Hultquist G., and Sevennerholm L. Malignant hyperlipemia in infancy. Am. J. Dis. Chile 107 (1964) 267-276
14. Fojo S.S., de Gennes J.L., Beisiegel U., Baggio G., Stalenhoef A.F., Brunzell J.D., and Brewer Jr. H.B. Molecular genetics of apoC-II and lipoprotein lipase deficiency. Adv. Exp. Med. Biol. 285 (1991) 329-333
15. Fojo S.S., and Brewer H.B. Hypertriglyceridaemia due to genetic defects in lipoprotein lipase and apolipoprotein C-II. J. Intern. Med. 231 (1992) 669-677